Pastilles climb past oil to become second largest SAS-B dosage form by Steve Jones December 2, 2025December 4, 2025 Pastilles have overtaken oil as the second-most prescribed dosage form for medicinal cannabis through the Special […]
‘Houston, we have a bit of a problem’: Chief TGA medical adviser flags systemic issues across sector by Adam Sheldon November 18, 2025February 21, 2026
TGA reviewing 751 submissions as industry outlines roadmap for reform by Adam Sheldon October 8, 2025October 8, 2025
Pastilles overtake oil among 18-44 age group as SAS-B approvals near 2024 total by Steve Jones October 1, 2025October 1, 2025
SAS-B approvals slow in August but pastille scripts continue to rise by Steve Jones September 3, 2025February 21, 2026
July SAS-B approvals edge higher as pastilles share rises beyond 20% by Adam Sheldon August 5, 2025August 6, 2025
SAS-B deep dive: approvals up 27% as flower officially overtakes oil by Adam Sheldon July 3, 2025July 3, 2025
May SAS-B approvals slip from April record but still close to 20,000 by Steve Jones June 3, 2025June 3, 2025
SAS-B approvals hit all-time high in April as Tasmania spikes again by Steve Jones May 2, 2025May 2, 2025
SAS-B approvals hit second highest on record as Tassie shows surprise growth by Steve Jones April 2, 2025April 2, 2025
